Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
about
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasisThe intrinsic disorder alphabet. III. Dual personality of serine.JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.Hypoxia-induced alternative splicing in endothelial cells.Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases.Magnetic resonance imaging detects placental hypoxia and acidosis in mouse models of perturbed pregnancies.Genetic loci for retinal arteriolar microcirculation.Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsiaNitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.The Histone Demethylase PHF8 Is Essential for Endothelial Cell Migration.JmjC Domain-containing Protein 6 (Jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-like 1 (Tcf7l1) and Is Required for Body Axis Patterning during Xenopus Embryogenesis.Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling.Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expressionJMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.Transcriptional and post-transcriptional control of adipocyte differentiation by Jumonji domain-containing protein 6.Global gene expression profiling of JMJD6- and JMJD4-depleted mouse NIH3T3 fibroblasts.Iron and diabetes riskProlyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes.The unfolded protein response in the protozoan parasite Toxoplasma gondii features translational and transcriptional control.TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.JMJD6 regulates ERα methylation on arginine.Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularizationSplice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic FunctionsHallmarks of alternative splicing in cancer.The oxygenase Jmjd6--a case study in conflicting assignments.Modifying the maker: Oxygenases target ribosome biology.Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness propertiesProtein arginine methylation/demethylation and cancer.The polyserine domain of the lysyl-5 hydroxylase Jmjd6 mediates subnuclear localization.Protein arginine methylation: a prominent modification and its demethylation.Vitamin D has wide regulatory effects on histone demethylase genes.Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine-serine-rich (RS) domains of SR- and SR-like proteins.Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.Twenty‑four signature genes predict the prognosis of oral squamous cell carcinoma with high accuracy and repeatability.Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice.Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.
P2860
Q29544441-0024E72F-AB18-490F-95F2-7AF0B51F66AEQ30399038-01C278EE-A227-4AD6-A74D-EBD90707909FQ33558243-5FE00E6A-6B76-4CFF-A33A-BAE7FF7677E9Q34372649-81B811AC-521A-4D4A-AB21-91F63CCF9EF1Q34483921-800C152D-0B35-48F5-834C-119545943BCBQ34652809-DEB9F3BA-4E7B-41FC-9BAD-6ECAE6618004Q34775960-78B03844-8796-4460-95AA-69A703824281Q35208938-B79A5381-A3FF-40C0-8D51-B0F3E2DEE28AQ35721088-5F13A849-A5AA-4ADD-863A-553D972A64AFQ35890073-7FF064E6-7118-4ED6-82D8-E3BFCB04715AQ35953126-F02E1087-5D56-4742-818D-AAEED82408F9Q36065272-0C6152B2-CD7D-4495-94C5-9C1693A1A233Q36188916-1BC5C846-B017-471F-8F10-66C454C0F199Q36245402-72C98D62-0386-40CE-8B80-29BE63B14229Q36299124-B65D3A11-86A0-49B0-BC3E-7DEC94535165Q36790684-260FB833-B08F-4F8B-8401-99229EA59E4BQ36827829-B715267F-A2A4-49A9-AFA4-E180C5F38879Q36916743-FA88DD67-8120-4F28-A435-0AD50F509802Q36970315-03D594E5-EF69-4A17-B0BD-29F4A15B4184Q37117794-2D66D2CC-7BFB-45CE-9997-2FBC70306448Q37507609-571951C2-A5BF-4767-ADE8-218CA241E052Q37549203-49E2AD18-144C-4890-88A0-326598C506FCQ37653350-5B348798-DA33-45AF-8219-D4E67BAC0FC7Q37690917-69827B60-C6E6-4333-B62E-A187CE4CC7E0Q37703058-D99F458C-8587-4AB8-9E62-AF6F45815D6FQ38171229-4218FF11-2404-4C52-8179-89F90A93AB91Q38495832-10429C23-AA61-4AB5-A17F-0B2DDA75A45CQ38700673-2224B0A8-F3A9-442D-A488-3C7A4A81B04EQ38813733-7EBBB61F-CA90-4309-BFA3-670AA061CC3CQ38935888-73E88FF4-F504-42A8-BA40-04E16072F84FQ39149725-31BB2585-8890-4912-BE1E-1DAE4872AF6EQ39212312-37BB12A3-7027-446D-A0F6-91817FD66B86Q39389302-AFC7EF3B-3B13-4992-ADAD-25A5EB28F2F1Q42719872-E7B1B10F-63B8-4533-A84F-C6919312E185Q46305857-2A9A2BBE-5483-4A77-8423-1C69694D36E5Q47283286-2FC76896-3FA0-4192-A2AC-EBEACAD5161BQ47662787-12AB3CDC-1CC9-48B5-BCB1-182ECED96E7EQ47894270-1FF1A6C3-3A7B-41B2-B6D3-891970B8FEF2Q49341169-2271BEE2-3011-4EAE-8A25-47A990720CB2Q52558418-03DE5E0A-21CB-4E2A-8658-037B7FD2F280
P2860
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
description
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2011
@ast
im Februar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/02/22)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/02/22)
@nl
наукова стаття, опублікована в лютому 2011
@uk
name
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@ast
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@en
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@nl
type
label
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@ast
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@en
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@nl
prefLabel
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@ast
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@en
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@nl
P2093
P2860
P50
P3181
P356
P1476
Jumonji domain-containing prot ...... es splicing of VEGF-receptor 1
@en
P2093
Andreas Lengeling
Jes-Niels Boeckel
Masamichi Koyanagi
Tino Roexe
Virginia Guarani
P2860
P304
P3181
P356
10.1073/PNAS.1008098108
P407
P577
2011-02-07T00:00:00Z